Curia to acquire LakePharma Curia, formerly known as Albany Molecular Research, has inked a deal to acquire private biologics firm LakePharma.Read More
Curia to acquire Integrity Bio Curia, formerly known as Albany Molecular Research, has inked a definitive agreement to acquire drug formulation and fill-finish provider Integrity Bio.Read More
ProfoundBio nabs $55M to advance ADC portfolio Oncology biotherapeutics company ProfoundBio has secured $55 million in funding that it plans to use to further develop its antibody-drug conjugate (ADC) portfolio, which includes a number of solid tumor-targeting candidates.Read More
Hummingbird Bioscience, MD Anderson team up on immunotherapies Hummingbird Bioscience and The University of Texas MD Anderson Cancer Center have entered into a multiyear research collaboration to investigate and develop HMBD-002, Hummingbird's V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) antagonist antibody.Read More